Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for BillionToOne, Inc. (BLLN : NSDQ)

• Company Description    BillionToOne Inc. is a molecular diagnostics company. BillionToOne Inc. is based in headquartered in Menlo Park, California. Number of Employees: 713

• Price / Volume Information    Yesterday's Closing Price: $104.67 Daily Weekly Monthly 20 Day Moving Average: 552,715 shares Shares Outstanding: 47.19 (millions) Market Capitalization: $4,939.07 (millions) Beta: 52 Week High: $150.44 52 Week Low: $61.96 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -8.52% -9.12% 12 Week -21.02% -25.51% Year To Date 27.90% 12.86%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1035 O`BRIEN DRIVE - MENLO PARK,CA 94025 USA ph: 650-460-2551 fax: - ir@billiontoone.com http://www.billiontoone.com

• General Corporate Information    Officers Oguzhan Atay - Chief Executive Officer and Director Ross Taylor - Chief Financial Officer David Tsao - Chief Technology Officer and Director Thomas Bremner - Director Firat Ileri - Director Peer Information BillionToOne, Inc. (BJCT) BillionToOne, Inc. (CADMQ) BillionToOne, Inc. (APNO) BillionToOne, Inc. (UPDC) BillionToOne, Inc. (IMTIQ) BillionToOne, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 090168105 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/04/26 Share - Related Items Shares Outstanding: 47.19 Most Recent Split Date: (:1) Beta: Market Capitalization: $4,939.07 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.16 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.80 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/04/26

• Fundamental Ratios P/E Current FY Estimate: 131.66 Trailing 12 Months: 149.53 PEG Ratio: - Price Ratios Price/Book: 9.13 Price/Cash Flow: 323.38 Price / Sales: 12.43 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -55.88% Sales Growth vs. Year Ago Period: 64.40% vs. Previous Quarter: 0.98% ROE 09/30/26 - - 06/30/26 - 9.96 03/31/26 - 12.68 ROA 09/30/26 - - 06/30/26 - 5.35 03/31/26 - 5.70 Current Ratio 09/30/26 - - 06/30/26 - 11.69 03/31/26 - 10.92 Quick Ratio 09/30/26 - - 06/30/26 - 11.31 03/31/26 - 10.58 Operating Margin 09/30/26 - - 06/30/26 - 8.04 03/31/26 - 6.67 Net Margin 09/30/26 - - 06/30/26 - 8.04 03/31/26 - 6.67 Pre-Tax Margin 09/30/26 - - 06/30/26 - 9.54 03/31/26 - 8.51 Book Value 09/30/26 - - 06/30/26 - 11.46 03/31/26 - 11.00 Inventory Turnover 09/30/26 - - 06/30/26 - 6.07 03/31/26 - 7.75 Debt-to-Equity 09/30/26 - - 06/30/26 - 0.17 03/31/26 - 0.18 Debt-to-Capital 09/30/26 - - 06/30/26 - 14.52 03/31/26 - 15.15

Powered by Zacks Investment Research ©